1. Clinical Drug Interaction Studies - Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions;FDA;FDA Guid,2020
2. Abbvie. QULIPTA (atogepant) product label and NDA reviews. Published online 2021. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215206Orig1s000TOC.cfm. Accessed July 20, 2022.
3. ChemoCentryx. TAVNEOS (avacopan) product label and NDA reviews. Published online 2021. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214487Orig1s000TOC.cfm. Accessed July 20, 2022.
4. Bayer HealthCare. Pharmaceuticals. KERENDIA (finerenone) product label and NDA reviews. Published online 2021. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215341Orig1s000TOC.cfm. Accessed July 20, 2022.
5. Pharmacokinetics of the novel, selective, non-steroidal mineralocorticoid receptor antagonist finerenone in healthy volunteers: results from an absolute bioavailability study and drug-drug interaction studies in vitro and in vivo;Heinig;Eur J Drug Metab Pharmacokinet,2018